肝再生对恶性肝肿瘤的影响。
Effect of liver regeneration on malignant hepatic tumors.
作者信息
Shi Ji-Hua, Line Pål-Dag
机构信息
Ji-Hua Shi, Pål-Dag Line, Department of Transplantation Medicine, Institute for Surgical Research, Oslo University Hospital, Postboks 4950, Nydalen 0424, Oslo, Norway.
出版信息
World J Gastroenterol. 2014 Nov 21;20(43):16167-77. doi: 10.3748/wjg.v20.i43.16167.
Abstract
Liver regeneration after major surgery may activate occult micrometastases and facilitate tumor growth, leading to liver tumor recurrence. Molecular changes during liver regeneration can provide a microenvironment that stimulates intrahepatic tumor propagation through alterations in cellular signaling pathways, where activation and proliferation of mature hepatocytes, hepatic progenitor cells, non-parenchymal liver cells might favor both liver regeneration and tumor growth. This review highlights recent advances of tumor growth and development in the regenerating liver, possible mechanisms and clinical implications.
摘要
大手术后的肝脏再生可能会激活隐匿的微转移灶并促进肿瘤生长，导致肝肿瘤复发。肝脏再生过程中的分子变化可提供一种微环境，通过细胞信号通路的改变刺激肝内肿瘤增殖，在此过程中成熟肝细胞、肝祖细胞、非实质肝细胞的激活和增殖可能对肝脏再生和肿瘤生长均有利。本文综述了再生肝中肿瘤生长和发展的最新进展、可能的机制及临床意义。
相似文献
1
Effect of liver regeneration on malignant hepatic tumors.肝再生对恶性肝肿瘤的影响。
World J Gastroenterol. 2014 Nov 21;20(43):16167-77. doi: 10.3748/wjg.v20.i43.16167.
2
Searching for the link; mechanisms underlying liver regeneration and recurrence of colorectal liver metastasis post partial hepatectomy.探寻联系：肝部分切除术后肝再生和结直肠肝转移复发的潜在机制。
J Gastroenterol Hepatol. 2019 Aug;34(8):1276-1286. doi: 10.1111/jgh.14644. Epub 2019 Mar 28.
3
[The Impact of Tumor Cell Proliferation on Occult Micrometastases, Tumor Recurrence and Patient Outcome Following Resection for Liver Malignancies].[肿瘤细胞增殖对肝脏恶性肿瘤切除术后隐匿性微转移、肿瘤复发及患者预后的影响]
Zentralbl Chir. 2016 Aug;141(4):375-82. doi: 10.1055/s-0042-108592. Epub 2016 Aug 24.
4
Refractory response to growth factors impairs liver regeneration after hepatectomy in patients with viral hepatitis.对生长因子的难治性反应会损害病毒性肝炎患者肝切除术后的肝脏再生。
Hepatogastroenterology. 2009 Jul-Aug;56(93):971-7.
5
[Research progress of the relationship between liver regeneration and tumor recurrence after hepatectomy].
Zhonghua Wai Ke Za Zhi. 2019 Jul 1;57(7):554-557. doi: 10.3760/cma.j.issn.0529-5815.2019.07.015.
6
RAF-targeted therapy for hepatocellular carcinoma in the regenerating liver.在再生肝脏中针对 RAF 的肝细胞癌靶向治疗。
J Surg Oncol. 2013 Mar;107(4):393-401. doi: 10.1002/jso.23224. Epub 2012 Aug 23.
7
Recent advances of radiofrequency ablation for early hepatocellular carcinoma.射频消融治疗早期肝细胞癌的最新进展。
J Gastroenterol Hepatol. 2011 Jan;26 Suppl 1:115-22. doi: 10.1111/j.1440-1746.2010.06543.x.
8
[Prognostic factors and outcome in patients with intrahepatic recurrence after hepatectomy for hepatocellular carcinoma].[肝细胞癌肝切除术后肝内复发患者的预后因素及结局]
Zhonghua Zhong Liu Za Zhi. 2009 Aug;31(8):612-6.
9
Liver regeneration stimulates tumor metastases.肝脏再生会刺激肿瘤转移。
J Surg Res. 2007 Apr;138(2):284-90. doi: 10.1016/j.jss.2006.06.024. Epub 2007 Jan 24.
10
Evaluating the current surgical strategies for hepatocellular carcinoma.评估肝细胞癌的当前手术策略。
Expert Rev Gastroenterol Hepatol. 2016;10(3):341-57. doi: 10.1586/17474124.2016.1116381. Epub 2015 Dec 10.
引用本文的文献
1
Epigenetic modifications in the murine liver upon depletion of transcriptional coregulator host cell factor 1.转录共调节因子宿主细胞因子1缺失后小鼠肝脏中的表观遗传修饰
BMC Genomics. 2025 Jul 11;26(1):654. doi: 10.1186/s12864-025-11786-5.
2
Liver transplantation for malignant liver tumors.恶性肝肿瘤的肝移植
ILIVER. 2022 Apr 18;1(1):3-11. doi: 10.1016/j.iliver.2022.04.002. eCollection 2022 Mar.
3
Experimental Liver Surgery for Liver Research: Update, Choice and Translation.用于肝脏研究的实验性肝脏手术：最新进展、选择与转化
J Inflamm Res. 2025 Mar 28;18:4497-4508. doi: 10.2147/JIR.S506737. eCollection 2025.
4
Activity-based sensing reveals elevated labile copper promotes liver aging via hepatic ALDH1A1 depletion.基于活性的传感显示，升高的不稳定铜通过肝脏ALDH1A1耗竭促进肝脏衰老。
Nat Commun. 2025 Feb 20;16(1):1794. doi: 10.1038/s41467-025-56585-4.
5
Prognostic nomogram for patients with advanced unresectable hepatocellular carcinoma treated with TAE combined with HAIC.经肝动脉栓塞术（TAE）联合肝动脉灌注化疗（HAIC）治疗的晚期不可切除肝细胞癌患者的预后列线图
Front Pharmacol. 2024 Aug 21;15:1426912. doi: 10.3389/fphar.2024.1426912. eCollection 2024.
6
Partial Hepatectomy Promotes the Development of KRASG12V-Induced Hepatocellular Carcinoma in Zebrafish.部分肝切除术促进斑马鱼中KRASG12V诱导的肝细胞癌的发展。
Cancers (Basel). 2024 May 8;16(10):1793. doi: 10.3390/cancers16101793.
7
Modelling the impact of liver regeneration on hepatoblastoma patient-derived-xenograft tumor growth.模拟肝再生对肝母细胞瘤患者来源异种移植瘤生长的影响。
Pediatr Res. 2024 Aug;96(3):668-677. doi: 10.1038/s41390-024-03020-x. Epub 2024 Jan 23.
8
Recent Advances in Liver Tissue Engineering as an Alternative and Complementary Approach for Liver Transplantation.肝脏组织工程作为肝移植替代和补充方法的最新进展
Curr Issues Mol Biol. 2023 Dec 29;46(1):262-278. doi: 10.3390/cimb46010018.
9
DNA Damage Repair Classifier Defines Distinct Groups in Hepatocellular Carcinoma.DNA损伤修复分类器在肝细胞癌中定义了不同的组别。
Cancers (Basel). 2022 Sep 1;14(17):4282. doi: 10.3390/cancers14174282.
10
The aberrant upregulation of exon 10-inclusive SREK1 through SRSF10 acts as an oncogenic driver in human hepatocellular carcinoma.通过 SRSF10 的异常上调，包含外显子 10 的 SREK1 作为人类肝细胞癌的致癌驱动因子发挥作用。
Nat Commun. 2022 Mar 16;13(1):1363. doi: 10.1038/s41467-022-29016-x.
本文引用的文献
1
Immunological effects of chemotherapy in spontaneous breast cancers.化疗对自发性乳腺癌的免疫效应
Oncoimmunology. 2013 Dec 1;2(12):e27158. doi: 10.4161/onci.27158. Epub 2013 Nov 14.
2
Immunogenic tumor cell death induced by chemoradiotherapy: molecular mechanisms and a clinical translation.放化疗诱导的免疫原性肿瘤细胞死亡：分子机制与临床转化。
Cell Death Dis. 2013 Jun 20;4(6):e688. doi: 10.1038/cddis.2013.207.
3
Cancer stem cells in the development of liver cancer.肝癌中的癌症干细胞。
J Clin Invest. 2013 May;123(5):1911-8. doi: 10.1172/JCI66024. Epub 2013 May 1.
4
Combined use of intraoperative ultrasound and indocyanine green fluorescence imaging to detect liver metastases from colorectal cancer.术中超声与吲哚菁绿荧光成像联合应用检测结直肠癌肝转移
HPB (Oxford). 2013 Dec;15(12):928-34. doi: 10.1111/hpb.12057. Epub 2013 Feb 20.
5
Liver transplantation for nonresectable liver metastases from colorectal cancer.肝移植治疗结直肠癌不可切除肝转移瘤。
Ann Surg. 2013 May;257(5):800-6. doi: 10.1097/SLA.0b013e3182823957.
6
Liver regeneration following partial hepatectomy is improved by enhancing the HGF/Met axis and Akt and Erk pathways after low-power laser irradiation in rats.低强度激光照射增强大鼠 HGF/Met 轴和 Akt、Erk 通路后可改善部分肝切除术后的肝再生。
Lasers Med Sci. 2013 Nov;28(6):1511-7. doi: 10.1007/s10103-013-1264-y. Epub 2013 Jan 20.
7
Enhanced tumor growth after portal vein embolization in a rabbit tumor model.兔肿瘤模型中门静脉栓塞后肿瘤生长增强。
J Surg Res. 2013 Mar;180(1):89-96. doi: 10.1016/j.jss.2012.10.032. Epub 2012 Nov 6.
8
Cellular immune responses to hepatocellular carcinoma: lessons for immunotherapy.肝细胞癌的细胞免疫反应：免疫治疗的启示。
Dig Dis. 2012;30(5):483-91. doi: 10.1159/000341697. Epub 2012 Oct 24.
9
CT versus MR imaging of hepatocellular carcinoma: toward improved treatment decisions.CT 与 MR 成像在肝细胞癌诊断中的比较：为了更好的治疗决策。
Magn Reson Med Sci. 2012;11(2):75-81. doi: 10.2463/mrms.11.75.
10
Growth factor pathways in development and progression of hepatocellular carcinoma.生长因子通路在肝细胞癌发生发展中的作用
Front Biosci (Schol Ed). 2012 Jun 1;4(4):1487-515. doi: 10.2741/s348.
Zotero 插件